Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Porst

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
European Urology|October 15, 2013
Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studiesHartmut Porst, Mauro Gacci, Hartwig Büttner, et al.
Urology|August 30, 2003
Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroupsHartmut Porst, Jay M Young, Abraham C Schmidt, et al.
European Urology|February 19, 2008
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaChristian G Stief, Hartmut Porst, Dieter Neuser, et al.
The Journal of Sexual Medicine|June 21, 2013
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studiesHartmut Porst, Claus G Roehrborn, Roberta J Secrest, et al.
The Journal of Sexual Medicine|October 21, 2014
Oxford School of Sexual Medicine: how are we doing?Lior Lowenstein, Yacov Reisman, Francesca Tripodi, et al.
European Urology|April 9, 2008
Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE studyJurgen Zumbé, Hartmut Porst, Frank Sommer, et al.
The Journal of Sexual Medicine|August 29, 2013
Physicians' attitude toward female genital plastic surgery: a multinational surveyLior Lowenstein, Andrea Salonia, Arik Shechter, et al.
European Urology|August 29, 2006
The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seekingHartmut Porst, Francesco Montorsi, Raymond C Rosen, et al.
Urology|July 3, 2003
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trialHartmut Porst, Harin Padma-Nathan, François Giuliano, et al.
European Urology|April 15, 2004
The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European menDimitrios Hatzichristou, Francesco Montorsi, Jacques Buvat, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
European Urology|October 15, 2013
Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studiesHartmut Porst, Mauro Gacci, Hartwig Büttner, et al.
Urology|August 30, 2003
Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroupsHartmut Porst, Jay M Young, Abraham C Schmidt, et al.
European Urology|February 19, 2008
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaChristian G Stief, Hartmut Porst, Dieter Neuser, et al.
The Journal of Sexual Medicine|June 21, 2013
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studiesHartmut Porst, Claus G Roehrborn, Roberta J Secrest, et al.
The Journal of Sexual Medicine|October 21, 2014
Oxford School of Sexual Medicine: how are we doing?Lior Lowenstein, Yacov Reisman, Francesca Tripodi, et al.
European Urology|April 9, 2008
Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE studyJurgen Zumbé, Hartmut Porst, Frank Sommer, et al.
The Journal of Sexual Medicine|August 29, 2013
Physicians' attitude toward female genital plastic surgery: a multinational surveyLior Lowenstein, Andrea Salonia, Arik Shechter, et al.
European Urology|August 29, 2006
The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seekingHartmut Porst, Francesco Montorsi, Raymond C Rosen, et al.
Urology|July 3, 2003
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trialHartmut Porst, Harin Padma-Nathan, François Giuliano, et al.
European Urology|April 15, 2004
The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European menDimitrios Hatzichristou, Francesco Montorsi, Jacques Buvat, et al.
Pageof 7